A new test provides a window into individual tumours

Ovarian cancer is an aggressive and deadly disease, with more than185,000 fatalities worldwide each year.

The high death toll is due to many patients developing resistance to chemotherapy, and while drugs exist that could overcome this problem, we lack the detailed, personalised information needed to choose which drug can target the tumour effectively.

Researchers at the University of New South Wales have targeted the waste product of a common medical procedure to develop a ‘liquid biopsy’ that provides unprecedented information about each individual cancer.

Continue reading Liquid biopsy helps target ovarian cancer with precision →